VERO Biotech
Manufacturing · Georgia, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
387 Technology Cir NW Ste 125, Atlanta, ...Phone Number
(678) 661-5701Website
www.vero-biotech.comRevenue
$21.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
4
1
1
1
1
About VERO Biotech
VERO Biotech LLC (formerly known as GeNO LLC) is a biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions.Explore more
VERO Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VERO Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if VERO Biotech is spiking on competitors!
VERO Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at VERO Biotech
Earning: See what the market has to say on VERO Biotech recently announced quarterly report
Product Launch: Get notified when VERO Biotech launches new products
Funding: Get notified immidiatlly once VERO Biotech has new funding data
Check if VERO Biotech has recently received funding, and reach out quickly before it becomes old news!
Click to see if VERO Biotech had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined VERO Biotech as Masked Content
Find 2 more new buyers
Compare Similar Companies to VERO Biotech
Compare insights from companies similar to VERO Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
VERO Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
VERO Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about VERO Biotech.
VERO Biotech financials insights
Gather financial insights about VERO Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$50M
Series E
$100M
2023
Other Financing Round
$30M
VERO Biotech Tech Stack
A closer look at the technologies used by VERO Biotech
See more technologies
Most Recent Scoops
Hiring Plans
VERO Biotech has more open roles in Finance than it has had at any time in the past 12 months. Areas of expertise include: Pharmacy Law, Gross Receipts Tax, Tax Research, State Taxes, Use Tax, Accounting Information Systems, and Annual Reports.
Hiring Plans
Open Position
Open Position
Open Position
Hiring Plans
Hiring Plans
VERO Biotech News & Media
VERO Biotech's Second Generation GENOSYL® Delivery System (DS) Receives FDA Approval in Anesthesia in the Surgical Suite
Second Generation GENOSYL® DS is the first and only Inhaled Nitric Oxide delivery system that is FDA-approved for rebreathing anesthesia, which provides a significant advantage in patient comfort, helping patients retain heat and moisture 1,2,3 ATLANTA, Feb. 2, 2023 /PRNewswire/ -- VERO...VERO Biotech Raises $30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery System
Financing led by Petrichor strengthens VERO Biotech's position as a leader in neonatal intensive care ATLANTA, Jan. 11, 2023 /PRNewswire/ -- VERO Biotech Inc., a commercial-stage healthcare business dedicated to neonatal intensive care and the acute care hospital community, today...VERO Biotech’s Tankless Inhaled Nitric Oxide Delivery System Gets FDA Approval
VERO Biotech received FDA approval of the newest generation of its tankless inhaled nitric oxide (iNO) delivery system.FDA OKs VERO Biotech’s Tankless Inhaled Nitric Oxide Delivery System
VERO Biotech announces that the U.S. FDA has approved the latest generation of its tankless inhaled nitric oxide delivery system.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VERO Biotech
Sign Up For FreeTo access detailed company insights
VERO Biotech LLC (formerly known as GeNO LLC) is a biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions.... Read More
